Decades of basic research in immunotherapy has resulted in dramatically improved cancer treatments for patients with tumors with high mutational burdens. The next challenge is to understand how to attack cancers with fewer mutations.
https://ift.tt/2IIOOTF
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου